Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agovaccine, Nuvaxovid. Since then, the stock has trended lower. The vaccine is based on protein...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via AOL· 7 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 1 day agoSmith recommends that “if you do test positive, then you need to talk to a doctor about whether or...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 6 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 5 days agoArexvy had an exceptional launch and generated...GSK expects Arexvy to generate more than £3 billion...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 5 days agoThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 5 days agoBoth Pfizer-BioNTech and Novavax are studying combination vaccines to protect against COVID-19 and influenza. Moderna: Combination vaccine</ ...
Moderna says combo COVID-flu vaccine showing promising results — and more
WGN Chicago via Yahoo News· 4 days agoModerna plans to file for federal approval this summer and hopes to have the vaccine available next...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...